Related articles

Experts share their insights on different health topics and how comprehensive healthcare solutions can treat different conditions to improve patient health.

From Data to Action: 3 Cancer Prevention Steps You Should Take in 2025

Each year, more than 20 million people worldwide are diagnosed with cancer — and increasingly, they are not just older adults. According to projections from the World Health Organization (WHO), global cancer cases may rise to nearly 30 million annually by 2040 if no active measures are taken.
This isn’t just a distant statistic — it’s a call to action.
And here’s the good news: Studies now suggest that up to 40% of cancers are preventable, especially when we intervene early with the right strategies.
At BMS, we believe that true prevention starts with the right knowledge, the right tools, and the right timing.

Read More »

Chelation Is Not an Extreme Therapy — It’s a Scientifically Grounded Deep Care Approach

When people hear the term “Chelation Therapy,” they often think of it as a last-resort detox method or something reserved for cases of heavy metal poisoning. However, this perspective is rapidly changing. In today’s world, where chronic exposure to toxins and environmental pollutants is common, chelation is being re-evaluated as a valuable tool in preventive, integrative, and functional health care.

Read More »

Want to Preserve Vascular Elasticity and Cellular Vitality? Get to Know PlaqX

Every day, our bodies face a constant battle against oxidative stress, chronic inflammation, and environmental toxins. As we age, cellular membranes weaken, vascular elasticity declines, and metabolic efficiency decreases—creating the perfect storm for chronic diseases and accelerated aging.
Many of these changes occur silently, long before any outward symptoms appear. That’s why more and more people focused on preventive health are turning to strategies that support cellular repair and vascular resilience.
One such approach gaining attention in Europe and Asia is PlaqX Therapy, a unique intravenous formulation designed to help restore inner vitality from the cellular level up.

Read More »

The “Invisible Support” in Cancer Care: A Gentle Introduction to Nutritional IV Immunoglobulin Therapy

When we talk about cancer care, the focus often centers on active treatments like surgery, chemotherapy, or targeted therapies. However, supportive care strategies also play a critical role in helping the body recover, maintain stability, and rebuild its strength. Among these strategies, intravenous nutritional immunoglobulin therapy (IVIG) is emerging as a promising and gentle option for additional support.

Read More »

An Overlooked Marker in Cancer Care: Do You Know Your Albumin Level?

In cancer care, most of the focus is placed on tumor markers, imaging results, or responses to treatment. Yet one often-overlooked blood marker—albumin—can quietly reflect a patient’s overall condition, prognosis, and even survival.
Though seemingly simple, this protein tells a deeper story about the body’s nutritional status, inflammation levels, and recovery capacity.

Read More »

RGCC Makes Nutritional Support a Data-Driven Decision—Not a Guessing Game

The wellness market is saturated with supplements—from vitamin C and D to herbal extracts and antioxidant blends.
Faced with overwhelming options, many people find themselves asking:
• “Do I really need to take all of these?”
• “Which one should I choose, and how much is enough?”
• “Are these supplements actually working for me?”
These questions point to the core issue:
Most people are making decisions about supplementation based on guesswork rather than science.
But in reality, nutritional support should be personalized, targeted, and data-driven.
This is where the RGCC Onconomics Plus test becomes a game-changer.

Read More »

Traditional Early Screening Looks for “Shape”, Onco-D-clare Identifies the “Source” — Which Do You Need?

When we talk about early cancer detection, most people think of imaging tests or tumor markers.
These tools are valuable for identifying structural abnormalities or elevated markers — in other words, when a disease has already begun to manifest.
But what if you could go one step earlier?
Before anything is visible or measurable, is there a way to understand your underlying genetic risk?

Read More »